RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome - PubMed (original) (raw)
RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome
Linde Duprez et al. Immunity. 2011.
Free article
Abstract
Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death. An additional switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis. We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS). Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS. However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amounts of circulating damage-associated molecular patterns. Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect. These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS. RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clinical relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment in
- Necroptosis turns TNF lethal.
Galluzzi L, Kroemer G. Galluzzi L, et al. Immunity. 2011 Dec 23;35(6):849-51. doi: 10.1016/j.immuni.2011.12.004. Immunity. 2011. PMID: 22195740
Similar articles
- Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R, Kakehashi H, Okumura K, Kumagai Y, Nakano H. Shindo R, et al. Biochem Biophys Res Commun. 2013 Jun 28;436(2):212-6. doi: 10.1016/j.bbrc.2013.05.075. Epub 2013 May 29. Biochem Biophys Res Commun. 2013. PMID: 23727581 - RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ, Cullen SP, Clancy D, Martin SJ. Kearney CJ, et al. FEBS J. 2014 Nov;281(21):4921-34. doi: 10.1111/febs.13034. Epub 2014 Oct 4. FEBS J. 2014. PMID: 25195660 - Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J, Dara L, Yang L, Aghajan M, Song Y, Kaplowitz N, Liu ZX. Suda J, et al. J Immunol. 2016 Oct 15;197(8):3120-3129. doi: 10.4049/jimmunol.1600690. Epub 2016 Sep 7. J Immunol. 2016. PMID: 27605011 Free PMC article. - RIPK1 and RIPK3: critical regulators of inflammation and cell death.
Newton K. Newton K. Trends Cell Biol. 2015 Jun;25(6):347-53. doi: 10.1016/j.tcb.2015.01.001. Epub 2015 Feb 4. Trends Cell Biol. 2015. PMID: 25662614 Review. - The diverse role of RIP kinases in necroptosis and inflammation.
Silke J, Rickard JA, Gerlic M. Silke J, et al. Nat Immunol. 2015 Jul;16(7):689-97. doi: 10.1038/ni.3206. Nat Immunol. 2015. PMID: 26086143 Review.
Cited by
- CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.
Legarda D, Justus SJ, Ang RL, Rikhi N, Li W, Moran TM, Zhang J, Mizoguchi E, Zelic M, Kelliher MA, Blander JM, Ting AT. Legarda D, et al. Cell Rep. 2016 Jun 14;15(11):2449-61. doi: 10.1016/j.celrep.2016.05.032. Epub 2016 Jun 2. Cell Rep. 2016. PMID: 27264187 Free PMC article. - A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants.
Sun ALA, Gillies JD, Shen Y, Deng H, Xue F, Ma Y, Song L. Sun ALA, et al. Clin Transl Sci. 2024 Jul;17(7):e13857. doi: 10.1111/cts.13857. Clin Transl Sci. 2024. PMID: 38949195 Free PMC article. Clinical Trial. - Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study.
Clot PF, Farenc C, Suratt BT, Krahnke T, Tardat A, Florian P, Pomponio R, Patel N, Wiekowski M, Lin Y, Terrier B, Staudinger H. Clot PF, et al. Respir Res. 2024 Feb 28;25(1):107. doi: 10.1186/s12931-024-02670-z. Respir Res. 2024. PMID: 38419035 Free PMC article. Clinical Trial. - RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated with Poor Prognosis in Patients with Alcoholic Cirrhosis.
Zhang Z, Xie G, Liang L, Liu H, Pan J, Cheng H, Wang H, Qu A, Wang Y. Zhang Z, et al. J Immunol Res. 2018 Nov 25;2018:1509851. doi: 10.1155/2018/1509851. eCollection 2018. J Immunol Res. 2018. PMID: 30596105 Free PMC article. - Pyroptosis versus necroptosis: similarities, differences, and crosstalk.
Frank D, Vince JE. Frank D, et al. Cell Death Differ. 2019 Jan;26(1):99-114. doi: 10.1038/s41418-018-0212-6. Epub 2018 Oct 19. Cell Death Differ. 2019. PMID: 30341423 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous